Awardee OrganizationSLOAN-KETTERING INST CAN RESEARCH
Description
Abstract Text
Abstract
The role of adipocytes in melanoma
The successful growth of primary tumors and establishment of metastases relies heavily on the suitability of the tumor
microenvironment. Adipocytes constitute a major portion of the melanoma TME in several cancer types but their
contribution to tumor progression is poorly understood. Here, we use an in vivo zebrafish melanoma transplantation model
and a co-culture system to investigate the cross-talk between adipocytes and melanoma. In fish, melanoma cells often in
subcutaneous sites show a 50% increase in lipid content compared to parental cells. This is accompanied by upregulation
of the long chain fatty acid (LCFA) fatty acid transporter proteins FATP2 and FATP6 and down regulation of lipid
synthesis genes, suggesting that the increase in lipids is derived from exogenous uptake from the surrounding
microenvironment. These data suggest that TME adipocytes can provide lipids to tumor cells. Consistent with this, fish
and human melanoma cells co-cultured with 3T3-L1 adipocytes also have increased lipid content, and fluorescently labeled
fatty acids can be transferred directly from adipocytes to melanoma cells. Moreover, co-culture with adipocytes makes
melanoma cells more invasive and proliferative. Lipid uptake by melanoma cells can be blocked with lipofermata, a small
molecule inhibitor of the FATP fatty acid transporters. Strikingly, lipofermata also has a profound anti-proliferative effect
on both human and zebrafish melanoma cells. Taken together, these data suggest that TME adipocytes play an important
role in melanoma growth, acting as a rich source of lipids for melanoma, and that uptake of these lipids is mediated by the
FATP fatty-acid transport proteins. The goal of the proposed research is to test the hypothesis that adipocytes in the
microenvironment aid in melanoma progression and metastases. To do so, we aim to elucidate how melanoma cells
influence adipocytes and vice versa. First, we will characterize the identify pathways and genes important in mediating
increased invasion and proliferation in cocultured tumor cells with gene expression analysis. Moreover, we will determine
whether adipocytes mediate metabolic reprogramming in melanoma cells, and test whether these phenotypic changes
depend on lipid uptake via FATP proteins. We will also use a transgenic zebrafish line with adipocyte-specific expression
of tdTomato-nitroreductase for imaging and isolation of adipocytes after tumor cell transplantation. Fish will imaged live to
characterize changes in adipocyte morphology in response to tumor burden. Further, adipocytes will be isolated via FACS
to characterize gene expression changes. Finally, adipocytes will be inducibly ablated using the NTR/metronidazole system
in the melanoma transplanted fish to functionally test the role of adipocytes in melanoma growth and metastases.
Ultimately, we wish to identify clinically targetable pathways of cross-talk between adipocytes and melanoma cells, which
represents a novel form of microenvironmental therapy for the treatment of melanoma.
Public Health Relevance Statement
Project Narrative
The tumor microenvironment plays an integral role in cancer progression. Though adipocytes make up an
extensive proportion of the tumor microenvironment in many cancers, their contribution to tumor progression
is poorly understood. The goal of the proposed research is to clarify the roles of adipocytes in melanoma
progression and metastasis, critical for understanding the tumor microenvironment and to guide the
development of effective microenvironment-based cancer therapeutics.
No Sub Projects information available for 5F32CA210536-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5F32CA210536-02
Patents
No Patents information available for 5F32CA210536-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5F32CA210536-02
Clinical Studies
No Clinical Studies information available for 5F32CA210536-02
News and More
Related News Releases
No news release information available for 5F32CA210536-02
History
No Historical information available for 5F32CA210536-02
Similar Projects
No Similar Projects information available for 5F32CA210536-02